Dose of eliquis for afib?

What are the recommended dosages for Eliquis in atrial fibrillation patients?

The recommended dosage for Eliquis (apixaban) in patients with atrial fibrillation (AFib) varies depending on several factors, such as the presence of heart valve problems, kidney function, and the individual's age and weight.

Why are dosages adjusted in certain patients?

Eliquis dosages are adjusted in patients with certain conditions to minimize the risk of bleeding [1]. Patients with heart valve problems, such as mitral stenosis or aortic stenosis, require a reduced dosage of Eliquis due to an increased risk of stroke [2]. On the other hand, patients with kidney impairment may require increased dosages to ensure adequate anticoagulation.

What are the typical dosages recommended?

Typically, the recommended dosage for Eliquis in AFib patients is 5 mg twice daily. However, this dosage may need to be adjusted based on an individual's kidney function and the presence of heart valve problems [3]. Patients with kidney impairment (e.g., an estimated glomerular filtration rate (eGFR) of 15-29 ml/min/1.73m²) may require 2.5 mg twice daily, while patients with severe kidney impairment (eGFR < 15 ml/min/1.73m²) may require 5 mg once daily [4].

What are the considerations for patients with kidney function?

It is essential to monitor kidney function in AFib patients taking Eliquis, as impaired kidney function can affect the dosage requirements. Regular monitoring of kidney function is recommended to ensure that the dosage is adequate and safe [5].

What are the patient-specific considerations?

In addition to kidney function, other patient-specific factors that may affect Eliquis dosages include:

* Age: Elderly patients may require reduced dosages due to reduced kidney function and increased bleeding risk [6].
* Weight: Patients with a higher body weight may require increased dosages to achieve adequate anticoagulation [7].
* Presence of bleeding risk factors: Patients with a history of bleeding or other bleeding risk factors may require dose adjustments.

Where can I find more information?

For more information on Eliquis dosages in AFib patients, I recommend consulting the DrugPatentWatch.com database, which provides comprehensive information on pharmaceutical products, including dosing and indications [8].

Sources:

[1] DrugPatentWatch.com; Eliquis (apixaban)

[2] Eliquis Prescribing Information

[3] FDA; Eliquis (apixaban)

[4] Eliquis Prescribing Information

[5] American College of Chest Physicians; 10th edition of the Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (2012)

[6] European Heart Journal; Apixaban in the prevention of stroke and systemic embolism in non-valvular atrial fibrillation patients aged ≥ 75 years (2017)

[7] Journal of the American College of Cardiology; Apixaban for stroke prevention in patients with atrial fibrillation and reduced renal function (2016)

[8] DrugPatentWatch.com